ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,000 | -82.9% | 16,650 | -52.8% | 0.00% | -100.0% |
| Q3 2020 | $117,000 | -17.0% | 35,293 | -16.2% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | -11.3% | 42,093 | +1.2% | 0.00% | 0.0% |
| Q1 2020 | $159,000 | -40.0% | 41,593 | -5.1% | 0.00% | -50.0% |
| Q4 2019 | $265,000 | -20.4% | 43,843 | -0.1% | 0.00% | 0.0% |
| Q3 2019 | $333,000 | -61.6% | 43,868 | -31.4% | 0.00% | -60.0% |
| Q2 2019 | $867,000 | +67.4% | 63,993 | -33.0% | 0.01% | +66.7% |
| Q1 2019 | $518,000 | +106.4% | 95,493 | +13.0% | 0.00% | +50.0% |
| Q4 2018 | $251,000 | -66.4% | 84,493 | -7.9% | 0.00% | -60.0% |
| Q3 2018 | $748,000 | -7.9% | 91,743 | +10.0% | 0.01% | -16.7% |
| Q2 2018 | $812,000 | +12.0% | 83,393 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $725,000 | -30.7% | 83,393 | 0.0% | 0.01% | -33.3% |
| Q4 2017 | $1,046,000 | – | 83,393 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 610,045 | $2,014,000 | 0.47% |
| ETF MANAGERS GROUP, LLC | 1,814,328 | $5,987,000 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,169 | $238,000 | 0.06% |
| Bernardo Wealth Planning LLC | 27,219 | $89,000 | 0.03% |
| Affinity Asset Advisors, LLC | 13,285 | $44,000 | 0.02% |
| ALGERT GLOBAL LLC | 20,778 | $69,000 | 0.02% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $164,000 | 0.01% |
| Founders Capital Management | 2,000 | $18,000 | 0.01% |
| King Wealth Management Group | 16,000 | $53,000 | 0.01% |
| Penserra Capital Management LLC | 129,252 | $425,000 | 0.01% |